New Delhi, Mar 16 (PTI) Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA). The New Jersey-based Sun Pharmaceutical Industries, Inc is recalling 9,840 bottles of Morphine Sulfate extended-release tablets for “Failed Dissolution Specifications”, the US health regulator stated …
As per news reports, Imarticus Learning will file a Draft Red Herring Prospectus (DRHP) with SEBI in the next 4-5 months. Facilitated by IIFL, the company plans to obtain SEBI’s approval by September 2025 and get publicly listed by early FY 2027. Organisations like Simplilearn, Classplus, and PhysicsWallah have already launched IPOs in the previous year. …
On March 17, 2025, SpiceJet announced that its Founder and Promoter, Ajay Singh, through M/s Spice Healthcare Private Limited, will inject ₹294.09 crore into the airline. This infusion will be executed through the conversion of 13.14 crore warrants into an equivalent number of equity shares. As a result, the Promoter Group’s consolidated shareholding in SpiceJet …
JB Chemicals & Pharmaceuticals Ltd announced on Friday, March 14, that its API (Active Pharmaceutical Ingredient) manufacturing facility (D9) in Panoli, Gujarat, has successfully cleared a US Food and Drug Administration (USFDA) inspection with no observations. Zero Observations from USFDA The inspection, conducted from March 10 to March 13, 2025, concluded without any Form 483 …
The uptick in Tata Steel’s share price today added to the gains of around 0.4% recorded in the previous session, reflecting continued investor interest. The stock rose 0.58% to ₹151.76 at 11:30 AM on the NSE, reaching an intraday high of ₹152.64 after opening at ₹151.99. It touched an intraday high of ₹152.64, and a low of …
Shilpa Medicare announced on Friday, March 14, that its wholly owned subsidiary, Shilpa Pharma Lifesciences Ltd, has successfully cleared a US Food and Drug Administration (USFDA) inspection at its Unit-2 facility in Raichur with zero observations. The inspection, conducted from March 10 to March 14, 2025, concluded without any Form 483 being issued. This marks …
On March 17, 2025, retail chain operator Vishal Mega Mart shares are in focus as the company’s shareholder lock-in period expires. As per news reports, the 3-month lock-in period will end on Monday, releasing 15.38 crore shares of the company for trading. These shares account for 3% of Vishal Mega Mart’s total outstanding equity. It’s important to …
MobiKwik Systems Ltd (NSE: MOBIKWIK) saw a significant decline in its share price on March 17, 2025, following the expiry of its three-month lock-in period for pre-IPO investors. On March 17, 2025, Mobikwik share price opened at ₹269.55, slightly down from its previous close of ₹270.65. At 10:34 AM, the share price of Mobikwik was …
Dalmia Bharat announced on Saturday, March 15, that its material subsidiary, Dalmia Cement (North East) Ltd, has commenced commercial production at its newly expanded cement grinding facility in Lanka, Hojai district, Assam. The expansion adds 2.4 million tonnes per annum (MTPA) to the company’s capacity. Boost to Total Manufacturing Capacity With this expansion, Dalmia Bharat …
On March 17, 2025, Hindustan Construction Company Limited (HCC), in partnership with Tata Projects Limited (TPL), has secured a ₹2,191 crore contract from the Madhya Pradesh Metro Rail Corporation Limited (MPMRCL) for the Indore Metro project. HCC holds a 55% share in the joint venture, valued at approximately ₹1,205 crore. Scope of the Project This …
